Implied Volatility Surging for Elevance Health Stock Options

Investors need to pay close attention to ELV stock based on the movements in the options market lately.

Zacks Investment Research • Oct 26, 2026

ELV vs. RVTY: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Revvity (RVTY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Oct 23, 2026

Elevance lifts 2026 profit forecast on better medical cost management

Elevance Health on Wednesday raised its annual profit forecast after posting better-than-expected quarterly ​results due to higher premiums and lower medical costs, driving the ‌health insurer's shares 2.1% higher in premarket trading.

Reuters • Oct 21, 2026

Elevance: 3 Key Takeaways for Long-Term Investors

Elevance raised its 2026 earnings baseline to at least $26.75 per share. Carelon's cancer program reduced avoidable inpatient admissions by 15%.

The Motley Fool • Oct 22, 2026

What Elevance Health (ELV) Said on Its Q3 Earnings Call

Elevance Health NYSE: ELV raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company's expectations as Medicaid, Medicare Advantage and Individual ACA businesses all performed better than anticipated.

MarketBeat • Oct 21, 2026

Elevance Health Raises Yearly Outlook as Profit, Revenue Rise

For the third quarter, the health-insurance company reported a rise in net income to $1.34 billion, or $6.27 a share, compared with $1.19 billion, or $5.32 a share, a year earlier.

WSJ • Oct 21, 2026

Elevance Health Reports Third Quarter 2026 Results; Raises Full-Year Guidance

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. "Elevance Health's third quarter results reflect stronger execution across our diversified portfolio and underscore the earnings power of the business. We are raising our 2026 earnings outlook and remain confident in delivering at least 12% growth in adjusted diluted earnings per share in 2027 from our higher earnings baseline of at least $26.753. By bringing together the.

Business Wire • Oct 21, 2026

Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript

Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript

Seeking Alpha • Oct 21, 2026

Elevance Health (ELV) Surpasses Q3 Earnings and Revenue Estimates

Elevance Health (ELV) came out with quarterly earnings of $6.99 per share, beating the Zacks Consensus Estimate of $4.66 per share. This compares to earnings of $6.03 per share a year ago.

Zacks Investment Research • Oct 21, 2026

Compared to Estimates, Elevance Health (ELV) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Oct 21, 2026